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Selective terminationWereport on the prenatal diagnosis through array CGHof a dichorionic–diamniotic (DC/DA) twins discordant for
Cri du Chat Syndrome. Structural anomalies on one of the twins lead to amniotic ﬂuid sampling, which revealed a
partial deletion on the short arm of the chromosome 5. Selective feticide of the affected twin was performed at
34 + 1 weeks' and elective Cesarean section at 37 + 2 weeks. Postnatal cytogenetic analysis conﬁrmed
pre-natal genetic ﬁndings.
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cri du Chat Syndrome (CdCS), is a genetic disease resulting from
a deletion of variable size on the short arm of chromosome 5,
OMIM#123450, with an incidence rate that ranges from 1:15.000
to 1:50.000 live-births.
Main clinical features include low weight at birth, high-pitched
monochromatic cat like cry, microcephaly, hypotonia, variable degree
of psychomotor and mental retardation, abnormal dermatoglyphics,
round face and dysmorphic facial features among others. Although not
very frequent, this syndrome can also encompass cardiac, neurological
and renal abnormalities that aggravate the vital prognosis.
Almost 80% of cases arise as de novo deletion, while 12% result from
unbalanced segregation of parental translocations, and less than 10% are
associated with cytogenetic rare aberrations [1].
Prenatal diagnosis of CdCS is rare, especially in cases with de novo
deletions. In this regard, the prenatal diagnosis is performed more
frequently among patients with a known parental 5p translocation
diagnosed in the context of a previous CdCS child.
2. Case Report
A 32-year-old nulligravida, without relevant medical history, preg-
nant with a DC/DA twin pregnancy after an in vitro fertilization cycle,
showed biochemical markers at 13+ 4weeks' gestation within normal03 Barcelona, Spain.
lez-Comadran).
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screening test. However, in the morphologic ultrasound a fetal growth
discordance was detected, motivating the transfer of the patient to our
center at the 24 weeks' gestation, where this ﬁnding was conﬁrmed.
In addition, a unilateral renal dysplasia was observed in the small
fetus, together with a mild dilation of the cavum septum pellucidum
as well as a fetal head and femur length biometries below the 5th
percentile, abnormalities conﬁrmed in subsequent examinations. Amni-
otic ﬂuid sampling of both sacs was performed at the 25 + 1 weeks,
which revealed a terminal deletion on the short arm of chromosome 5
(46XY,?del(5)(p13)) of the abnormal fetus (Fig. 1) and euploid karyotype
of the healthy twin (46XX). Molecular analysis through array CGH (qChip
Pre® v1.1 Complete. Quantitative Genomics Medicine Laboratories, S.L.)
conﬁrmed a distal 5p deletion of considerable size (~26,7 Mb), ranging
from 5p15.33 to p14.1 (Fig. 1). Karyotype of both progenitors was also
studied, excluding parental chromosomal rearrangements.
Genetic counseling provided with a detailed prognosis of this
syndrome, and accordingly selective termination of the abnormal
fetus was offered, and later approved by the Ethics Committee.
At the 33 + 2 weeks, the selective feticide was performed suc-
cessfully by transabdominal injection of intracardiac potassium
chloride in the anomalous fetus under ultrasonographic guidance,
after completing fetal lung maturation of the healthy fetus. In subse-
quent examinations, a ﬂattening in the growing curve of the healthy
fetus was observed, placing fetal biometry down to the 16th percen-
tile. Elective Cesarean section was performed at 37 + 2 weeks, with
the birth of a girl small for her gestational age (2390 g), APGAR score
9/10/10, arterial and venous umbilical cord pHs of 7.34 and 7.35,C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Detail of molecular karyotype with the terminal deletion on 5p: Arr 5p15.33p14.1(131,946–26,885,727)x1,(XY)x1.
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signiﬁcant signs of soaking.3. Discussion
In the literature, the prenatal diagnosis of CdCS cases is uncommon,
precisely because of the lack of speciﬁc sonographic signs and biochem-
ical marker that suggest this syndrome. Hence, themajority of cases are
detected unexpectedly after performing a karyotype analyses when
seeking other chromosomal alterations that would be more commonly
observed. Several authors have reported alterations in the levels of
maternal serum beta-human chorionic gonadotrophin (Beta-hCG),
either low [2] or elevated [3], while others have described morphologic
sonographic alterations, that either way lead to the performance of a
karyotype.
In the case presented herein, the diagnosis by karyotype was
performed because of a restriction in the fetal growing curve to-
gether with renal and neurological anomalies, although levels of
maternal serum Beta-hCG in the ﬁrst trimester were within normal
range. Through cytogenetic molecular analysis, we were able to de-
tect and describe accurately a deletion in the short arm of the chro-
mosome 5 that encompassed the regions 5p15.33 to p14.1.
In this regard, the introduction of cytogenetic molecular analy-
sis has offered the possibility to identify certain critical regions
within 5p, and has led several authors to deﬁne a correlation geno-
type–phenotype, by describing concrete regions associated with
certain clinical features, such as the typical cry, speech delay,microcephaly, facial dysmorphology, and most importantly mental
retardation [4,5].
In this context, the use of array CGH has offered an exceptional accu-
racy at detecting gain or loss in genetic material [6,7], with higher reso-
lution and efﬁciency than standard cytogenetics. Interestingly, Zhang
et al. [6] through array CGH, were able to detect more accurately the lo-
cation of genes involved in the typical cry, facial features and speech
delay, and reﬁned the genotype–phenotype correlation. Additionally,
they described three chromosomal regions that inﬂuence in different
ways the level of mental retardation (MR) (MRI to III), assigning a dom-
inant role to MRI, whose deletions have been associated to moderate
level of mental retardation. Deletions restricted to either MRII or MRIII
in their proximal part to MRI have been described to produce either
mild forms of mental retardation or no discernible phenotype at all, re-
spectively. However, as the deletion of MRI extended progressively into
MRII and MRIII the severity of the mental retardation was dramatically
aggravated [6]. Individualizing this information in the case presented
herein, the deletion described encompassed bands 5p15.33 to p14.1,
where not only the regions for speech, cry and facial features are con-
ﬁned, but also regions for MRI to III, aggravating the prognosis of the af-
fected twin. To a certain extent, this accurate information that array
CGH may offer in terms of prognosis is rather relevant in clinical prac-
tice, and could provide thereby a more individualized genetic counsel-
ing to the progenitors.
Another relevant question to address is the adequate timing to per-
forma selective feticide in a twin pregnancy discordant for a fetal anom-
aly. In cases of lethal malformations expectant management could be a
safe alternative. However, when selective feticide is considered, the
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its inherent adverse events. In fact, the absence of placental anastomo-
ses in dichorionic pregnancies reduces the incidence of complications,
although the risk of preterm delivery remains intact.
To date, there is no consensus about the optimal gestational age at
which to perform this procedure in order to avoid fetal loss or extreme
prematurity of the healthy fetus. Experts recommend performing the
selective feticide as early as possible, since the risk of miscarriage
increases considerably after the 16 weeks. However, when the discor-
dant congenital defect is detected after 24 weeks, the performance of
the selective feticide after 30 weeks, when legally feasible, and individ-
ualizing the exact timing according to the maternal cervical conditions,
could be an alternative in order to reach optimal perinatal outcomes, by
reducing pregnancy loss and extreme prematurity [8].
Funding Sources
None.
Conﬂicts of Interest
None declared.References
[1] Niebuhr E. The cri du chat syndrome: epidemiology, cytogenetics, and clinical
features. Hum Genet 1978;44:227–75.
[2] Weiss A, Shalev S, Weiner E, et al. Prenatal diagnosis of 5p deletion syndrome follow-
ing abnormally low maternal serum human chorionic gonadotrophin. Prenat Diagn
2003(23):572–4.
[3] Torun D, Bahce M, Alanbay I, et al. Prenatal diagnosis of cri-du chat syndrome follow-
ing high maternal serum human chorionic gonadotrophin and choroid plexus cysts.
Prenat Diagn 2009;29:536–7.
[4] Overhauser J, Huang X, GershM, et al. Molecular and phenotypicmapping of the short
arm of chromosome 5: sublocalization of the critical region for the cri-du-chat
syndrome. HumMol Genet 1994;3:247–52.
[5] Medina M, Marinescu RC, Overhauser J, Kosik KS. Hemizygosity of delta-catenin
(CTNND2) is associated with severe mental retardation in cri-du-chat syndrome.
Genomics 2000;63:157–64.
[6] Zhang X, Snijders A, Segraves R, et al. High-resolution mapping of genotype–pheno-
type relationships in cri du chat syndrome using array comparative genomic hybrid-
ization. Am J Hum Genet 2005;76:312–26.
[7] Harvard C, Malenfant P, Koochek M, et al. A variant cri du chat phenotype and autism
spectrum disorder in a subject with de novo cryptic microdeletions involving 5p15.2
and 3p24.3–25 detected using whole genomic array CGH. Clin Genet 2005;67:
341–51.
[8] Alvarado EA, Pacheco RP, Alderete FG, et al. Selective termination in dichorionic twins
discordant for congenital defect. Eur J Obstet Gynecol Reprod Biol 2012;161:8–11.
